Form 4: American Oncology Network's General Counsel, Erica Mallon, Receives Stock Grant

Erica Mallon, General Counsel of American Oncology Network, Inc., was granted 36,000 shares of Class A Common Stock for her service to the company.

Summary

• Erica Mallon, the General Counsel of American Oncology Network, Inc. (AONC), received a grant of 36,000 shares of Class A Common Stock on July 16, 2024.
• The shares were granted for her service as General Counsel.
• 23,400 shares will vest on a time-based vesting schedule over four years.
• 12,600 shares will vest based on a performance-based vesting schedule.
• A Form 4 filing was submitted to the SEC on July 18, 2024.
• Mallon has granted Stephen Spivey, Ashley Knox, and Ryan Edenfield power of attorney for Section 16 reporting obligations.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The stock grant aligns the General Counsel's interests with the company's success.
• Vesting schedules encourage long-term commitment and performance.

Future Outlook

The vesting of the shares is contingent on continued service and performance, aligning the General Counsel's incentives with the company's long-term goals.

Industry Context

Stock grants are a common form of executive compensation in the healthcare industry, used to attract and retain talent and align their interests with shareholder value.

Comparison to Industry Standards

• Stock grants for General Counsels in similar-sized oncology companies typically range from \$100,000 to \$500,000 in value, depending on experience and company performance.
• Vesting schedules are standard practice, with time-based vesting over 3-5 years and performance-based vesting tied to specific company milestones.
• Companies like McKesson and Cardinal Health also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns executive interests with company performance.
• Employees may see it as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Form 4, beneficial ownership, stock grant, General Counsel, Erica Mallon, American Oncology Network, AONC, Section 16